Impact of vitrectomy on outcomes of treatment for diabetic macular oedema with intravitreal ranibizumab
Sheelah Antao(Moorfields Eye Hospital), Ranjan Rajendram(University College London), James Bainbridge(University College London), Roger Wong(Frimley Park Hospital), Mark A. P. Fajgenbaum(St Thomas' Hospital), Namritha Patrao(Moorfields Eye Hospital), Lyndon da Cruz(Moorfields Eye Hospital)
UCL Discovery (University College London)
September 26, 2016
Cited by 0
Related Papers
A Prospective Randomized Trial of Intravitreal Bevacizumab or Laser Therapy in the Management of Diabetic Macular Edema (BOLT Study)
|Ophthalmology|2010|510
Patterns of Peripheral Retinal and Central Macula Ischemia in Diabetic Retinopathy as Evaluated by Ultra-widefield Fluorescein Angiography
|American Journal of Ophthalmology|2014|142
Induction of Differentiation by Pyruvate and DMEM in the Human Retinal Pigment Epithelium Cell Line ARPE-19
|Investigative Ophthalmology & Visual Science|2011|101
Real-World Outcomes of Ranibizumab Treatment for Diabetic Macular Edema in a United Kingdom National Health Service Setting
|American Journal of Ophthalmology|2016|86
Widefield optical coherence tomography angiography for early detection and objective evaluation of proliferative diabetic retinopathy
|British Journal of Ophthalmology|2020|68